University Hospitals Birmingham NHS Foundation Trust

Medicines A–Z

B

Status Drug name NICE TAs Comments
Status: Red Brodalumab (Kyntheum®)
Status: Red Brolucizumab (Beovu®)
Status: Red Bromocriptine tablets
Status: Amber Bromonidine eye drops

Specialist ophthalmologist recommendation

Status: Green Budenoside and Formoterol (Symbicort)

For asthma only. Non-formulary for COPD.

Status: Green Budenoside nebulised
Status: Red Budesonide 1mg orodispersible tablets (Jorveza®)
Status: Amber Budesonide 2mg rectal foam (2mg per 1 metered dose) (Budenofalk®)

Approved to support the shortage of Colifoam (June 2018)

Status: Red Budesonide 9mg prolonged-release tablets (Cortiment®)
Status: Amber Budesonide capsules (Budenofalk capsules 3mg)

Consultant initiation only

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top